107 related articles for article (PubMed ID: 19447853)
1. Is the physical decay correction of the (18)F-FDG input function in dynamic PET imaging justified?
Laffon E; Barret O; Marthan R; Ducassou D
J Nucl Med Technol; 2009 Jun; 37(2):111-3. PubMed ID: 19447853
[TBL] [Abstract][Full Text] [Related]
2. Spillover and partial-volume correction for image-derived input functions for small-animal 18F-FDG PET studies.
Fang YH; Muzic RF
J Nucl Med; 2008 Apr; 49(4):606-14. PubMed ID: 18344438
[TBL] [Abstract][Full Text] [Related]
3. The use of molecular sieves to simulate hot lesions in (18)F-fluorodeoxyglucose--positron emission tomography imaging.
Matheoud R; Secco C; Ridone S; Inglese E; Brambilla M
Phys Med Biol; 2008 Apr; 53(8):N137-48. PubMed ID: 18379022
[TBL] [Abstract][Full Text] [Related]
4. Simplifications in analyzing positron emission tomography data: effects on outcome measures.
Logan J; Alexoff D; Kriplani A
Nucl Med Biol; 2007 Oct; 34(7):743-56. PubMed ID: 17921027
[TBL] [Abstract][Full Text] [Related]
5. Correction for the effect of rising plasma glucose levels on quantification of MR(glc) with FDG-PET.
Dunn JT; Anthony K; Amiel SA; Marsden PK
J Cereb Blood Flow Metab; 2009 May; 29(5):1059-67. PubMed ID: 19293824
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
[TBL] [Abstract][Full Text] [Related]
7. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
[TBL] [Abstract][Full Text] [Related]
8. Giant cell arteritis on 18F-FDG PET/CT.
Heston TF; Szabo Z
Clin Physiol Funct Imaging; 2009 Sep; 29(5):382-4. PubMed ID: 19522856
[TBL] [Abstract][Full Text] [Related]
9. Practical Aspects of 18F-FDG PET When Receiving 18F-FDG from a Distant Supplier.
Ducharme J; Goertzen AL; Patterson J; Demeter S
J Nucl Med Technol; 2009 Sep; 37(3):164-9. PubMed ID: 19692456
[TBL] [Abstract][Full Text] [Related]
10. The total amount of uptake may affect the input function: a theoretic approach about 18F-FDG PET imaging.
Laffon E; Marthan R
Nucl Med Biol; 2015 Sep; 42(9):724-7. PubMed ID: 25960434
[TBL] [Abstract][Full Text] [Related]
11. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.
Cheon GJ; Kim MS; Lee JA; Lee SY; Cho WH; Song WS; Koh JS; Yoo JY; Oh DH; Shin DS; Jeon DG
J Nucl Med; 2009 Sep; 50(9):1435-40. PubMed ID: 19690035
[TBL] [Abstract][Full Text] [Related]
12. Image-derived input function from the vena cava for 18F-FDG PET studies in rats and mice.
Lanz B; Poitry-Yamate C; Gruetter R
J Nucl Med; 2014 Aug; 55(8):1380-8. PubMed ID: 24914058
[TBL] [Abstract][Full Text] [Related]
13. Microfluidic technology for PET radiochemistry.
Gillies JM; Prenant C; Chimon GN; Smethurst GJ; Dekker BA; Zweit J
Appl Radiat Isot; 2006 Mar; 64(3):333-6. PubMed ID: 16290947
[TBL] [Abstract][Full Text] [Related]
14. Collagen-based matrices improve the delivery of transplanted circulating progenitor cells: development and demonstration by ex vivo radionuclide cell labeling and in vivo tracking with positron-emission tomography.
Zhang Y; Thorn S; DaSilva JN; Lamoureux M; DeKemp RA; Beanlands RS; Ruel M; Suuronen EJ
Circ Cardiovasc Imaging; 2008 Nov; 1(3):197-204. PubMed ID: 19808543
[TBL] [Abstract][Full Text] [Related]
15. Single 20-second acquisition of deep-inspiration breath-hold PET/CT: clinical feasibility for lung cancer.
Torizuka T; Tanizaki Y; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Ouchi Y
J Nucl Med; 2009 Oct; 50(10):1579-84. PubMed ID: 19759111
[TBL] [Abstract][Full Text] [Related]
16. [18F]2-fluoro-2-deoxyglucose positron emission tomography/computed tomography in predicting radiation pneumonitis.
Song H; Yu JM; Kong FM; Lu J; Bai T; Ma L; Fu Z
Chin Med J (Engl); 2009 Jun; 122(11):1311-5. PubMed ID: 19567143
[TBL] [Abstract][Full Text] [Related]
17. Radiolysis of 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) and the role of ethanol and radioactive concentration.
Jacobson MS; Dankwart HR; Mahoney DW
Appl Radiat Isot; 2009 Jun; 67(6):990-5. PubMed ID: 19231219
[TBL] [Abstract][Full Text] [Related]
18. A bone marrow F-18 FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivity.
Inoue K; Goto R; Okada K; Kinomura S; Fukuda H
Ann Nucl Med; 2009 Sep; 23(7):643-9. PubMed ID: 19629627
[TBL] [Abstract][Full Text] [Related]
19. Gender dependent rate of metabolism of the opioid receptor-PET ligand [18F]fluoroethyldiprenorphine.
Henriksen G; Spilker ME; Sprenger T; Hauser AI; Platzer S; Boecker H; Toelle TR; Schwaiger M; Wester HJ
Nuklearmedizin; 2006; 45(5):197-200. PubMed ID: 17043729
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of assessing [(18)F]FDG lung metabolism with late dynamic PET imaging.
Laffon E; de Clermont H; Vernejoux JM; Jougon J; Marthan R
Mol Imaging Biol; 2011 Apr; 13(2):378-84. PubMed ID: 20524071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
